10074-G5

Suppliers

Names

[ CAS No. ]:
413611-93-5

[ Name ]:
10074-G5

[Synonym ]:
N-[1,1 inverted exclamation marka-Biphenyl-2-yl]-7-nitro-2,1,3-Benzoxadiazol-4-amine
N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-amine
2,1,3-Benzoxadiazol-4-amine, N-[1,1'-biphenyl]-2-yl-7-nitro-
N-(2-Biphenylyl)-7-nitro-2,1,3-benzoxadiazol-4-amine
Biphenyl-2-yl-(7-nitro-benzo[1,2,5]oxadiazol-4-yl)-amine
7-nitro-N-(2-phenylphenyl)-2,1,3-benzoxadiazol-4-amine
10074-G5

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
538.6±60.0 °C at 760 mmHg

[ Molecular Formula ]:
C18H12N4O3

[ Molecular Weight ]:
332.313

[ Flash Point ]:
279.5±32.9 °C

[ Exact Mass ]:
332.090942

[ PSA ]:
96.77000

[ LogP ]:
4.97

[ Vapour Pressure ]:
0.0±1.4 mmHg at 25°C

[ Index of Refraction ]:
1.719

[ Storage condition ]:
-20℃

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS06

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H301-H315-H319-H335

[ Precautionary Statements ]:
P261-P301 + P310-P305 + P351 + P338

[ RIDADR ]:
UN 2811 6.1 / PGIII

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 2-Aminodiphenyl
  • 4-Chloro-7-nitrobenzofurazan

DownStream

Articles

Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.

Oncotarget 6 , 38934-51, (2015)

Leukemia remains life-threatening despite remarkable advances in chemotherapy. The poor prognosis and drug resistance are challenging treatment. Novel drugs are urgently needed. Shikonin, a natural na...

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential.

Oncotarget 5(19) , 8869-78, (2014)

The oncogenic bHLH-LZ transcription factor Myc forms binary complexes with its binding partner Max. These and other bHLH-LZ-based protein-protein interactions (PPI) in the Myc-Max network are essentia...

Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion.

Oncotarget 6 , 15857-70, (2015)

The c-Myc (Myc) oncoprotein is deregulated in a large proportion of diverse human cancers. Considerable effort has therefore been directed at identifying pharmacologic inhibitors as potential anti-neo...


More Articles

Related Compounds

  • aesculioside G5
  • JAK2 inhibitor G5-7
  • 4,6-O-3-Ketobutylidene maltopentaose
  • 3-(3-(3,6-dichloro-9H-carbazol-9-yl)-2-hydroxypropyl)thiazolidine-2,4-dione
  • G5
  • Methyl 3-[3-(methylthio)phenoxy]propanoate
  • 4-Amino-2-carboxy-1H-pyrrole-1-acetic acid
  • 4,5-Diphenyl-1H-imidazole-1-propanenitrile
  • 1-Butyl-2-methyl-1H-pyrrolo[2,3-b]pyridine
  • 3,5-Dinitro[1,1a(2)-biphenyl]-2-yl pentanoate
  • 4-Ethynyl-1-fluoro-2-(fluoromethyl)benzene
  • 1-(2-Amino-3-ethyl-5-methylphenyl)ethanone
  • 1-Chloro-6,7-difluoro-9,10-anthracenedione
  • 3-[(1R)-1-Aminobutyl]benzenepropanoic acid
  • 5-Bromo-6-methyl-3-phenyl-2(1H)-pyrazinone